Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

NCT05672927 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

618

Enrollment

OTHER

Sponsor class

Conditions

Immunization
HPV Infection
Human Papillomavirus

Interventions

BIOLOGICAL: 9-valent HPV vaccine, 2 doses alternate timing
BIOLOGICAL: 9-valent HPV vaccine, 3 doses standard timing

Sponsor

The University of Texas Medical Branch, Galveston

Collaborators

[object Object]